Key Coronary Artery Bypass Graft Market Players:
- Medtronic, plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Guidant Group
- Xeltis BV
- MAQUET Holding B.V. & Co.KG
- Novadaq Technologies Inc.
- KARL STORZ GmbH & Co. KG
- Edwards Lifesciences Corporation
- Genesee Biomedical Inc.
- Sorin Group
- Kimal PLC
Key players in the coronary artery bypass graft market are contributing through innovations in surgical techniques, technology, and healthcare solutions. Investments and partnerships among government and private sectors are improving the quality and accessibility of CABG procedures and are also contributing to the overall growth of the market by making the surgeries more efficient across diverse regions.
Here are some key players in the coronary artery bypass graft market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of coronary artery bypass graft is evaluated at USD 14.73 billion.
Coronary Artery Bypass Graft Market size was over USD 13.73 billion in 2024 and is poised to exceed USD 31.33 billion by 2034, growing at over 8.6% CAGR during the forecast period i.e., between 2025-2034.
North America is expected to dominate largest industry share of 49.8% by 2034.
The key market players include Guidant Group, MAQUET Holding B.V. & Co.KG, Novadaq Technologies Inc., KARL STORZ GmbH & Co. KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc., and others.
